<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>661</number>
    <updateDate>2025-04-02T19:45:46Z</updateDate>
    <updateDateIncludingText>2025-04-02T19:45:46Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2025-01-23</introducedDate>
    <congress>119</congress>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 171, Number 14 (Thursday, January 23, 2025)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. BUCHANAN:H.R. 661.Congress has the power to enact this legislation pursuantto the following:Article 1, section 8.[Page H388]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2025-01-23T15:05:50Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2025-01-23</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2025-01-23</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-01-23</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>B001260</bioguideId>
        <fullName>Rep. Buchanan, Vern [R-FL-16]</fullName>
        <firstName>Vern</firstName>
        <lastName>Buchanan</lastName>
        <party>R</party>
        <state>FL</state>
        <district>16</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>S001200</bioguideId>
        <fullName>Rep. Soto, Darren [D-FL-9]</fullName>
        <firstName>Darren</firstName>
        <lastName>Soto</lastName>
        <party>D</party>
        <state>FL</state>
        <district>9</district>
        <sponsorshipDate>2025-01-23</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001215</bioguideId>
        <fullName>Rep. Miller-Meeks, Mariannette [R-IA-1]</fullName>
        <firstName>Mariannette</firstName>
        <lastName>Miller-Meeks</lastName>
        <party>R</party>
        <state>IA</state>
        <district>1</district>
        <sponsorshipDate>2025-01-23</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Advanced technology and technological innovations</name>
          <updateDate>2025-03-17T17:40:41Z</updateDate>
        </item>
        <item>
          <name>Advisory bodies</name>
          <updateDate>2025-03-17T17:41:21Z</updateDate>
        </item>
        <item>
          <name>Diplomacy, foreign officials, Americans abroad</name>
          <updateDate>2025-03-17T17:40:21Z</updateDate>
        </item>
        <item>
          <name>Employment and training programs</name>
          <updateDate>2025-03-17T17:41:04Z</updateDate>
        </item>
        <item>
          <name>Health promotion and preventive care</name>
          <updateDate>2025-03-17T17:40:54Z</updateDate>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
          <updateDate>2025-03-17T17:40:36Z</updateDate>
        </item>
        <item>
          <name>Intellectual property</name>
          <updateDate>2025-03-17T17:40:47Z</updateDate>
        </item>
        <item>
          <name>Israel</name>
          <updateDate>2025-03-17T17:40:13Z</updateDate>
        </item>
        <item>
          <name>Manufacturing</name>
          <updateDate>2025-03-17T17:40:59Z</updateDate>
        </item>
        <item>
          <name>Medical research</name>
          <updateDate>2025-03-17T17:40:26Z</updateDate>
        </item>
        <item>
          <name>Prescription drugs</name>
          <updateDate>2025-03-17T17:41:25Z</updateDate>
        </item>
        <item>
          <name>Public-private cooperation</name>
          <updateDate>2025-03-17T17:41:16Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2025-02-24T14:01:51Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2025-01-23</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2025-04-02T19:44:52Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes&amp;nbsp;HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the programâ€™s purposes.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>MIRACLE Medical Technology Act of 2025</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>MIRACLE Medical Technology Act of 2025</title>
        <updateDate>2025-02-22T06:23:50Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>MIRACLE Medical Technology Act of 2025</title>
        <updateDate>2025-02-22T06:23:21Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025</title>
        <updateDate>2025-02-22T06:23:21Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To require the Secretary of Health and Human Services, in consultation with the Secretary of Commerce, the Council for Technology and Innovation of the Centers for Medicare &amp; Medicaid Services, and the Commissioner of Food and Drugs, to carry out a program to facilitate and coordinate efforts between the United States and Israel to expand and enhance collaboration on the development and delivery of health care products and services.</title>
        <updateDate>2025-02-22T06:18:43Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2025-01-23T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119hr661ih/xml/BILLS-119hr661ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2025-01-23</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
